Using nanopore sequencing in liver transplant patients
Part of Infections clinical trials.
This trial uses a new DNA-sequencing method, nanopore adaptive sequencing, to monitor liver transplant patients. It aims to see if this technology can better track their health after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to receive a liver transplant.
- You are willing and able to give informed consent to take part.
- You can understand the information about the study.
- You are not currently in another clinical trial.
- You have not had a previous organ transplant or a multi-organ transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if monitoring antibiotic levels in the blood can help doctors give the right dose to liver transplant patients with serious bacterial infections. The goal is to make the treatment work better.
This trial tests whether using a sensitive DNA test (mNGS) to find the exact cause of an infection leads to better treatment for liver transplant recipients who got an infection from their donor.
This trial uses a DNA test to better detect infections in people with advanced liver disease who are hospitalized. It may help doctors find the right treatment faster.
This study collects health and genetic information from children who have had a liver or kidney transplant, to better understand their long-term health. It aims to improve care while protecting patient privacy.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
This study looks at how well noninvasive tests (tests that don’t require surgery or taking tissue) can detect complications after a liver transplant. It may help patients and teams find problems earlier using safer, easier monitoring.
Hear when a new Liver Transplant Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.